
November 3, 2017 - By Stephen Andrade
Sarbit Advisory Services Inc decreased its stake in T Mobile Us Inc (TMUS) by 14.44% based on its latest 2017Q2 regulatory filing with the SEC. Sarbit Advisory Services Inc sold 110,000 shares as the company’s stock rose 3.83% with the market. The institutional investor held 652,000 shares of the public utilities company at the end of 2017Q2, valued at $39.52 million, down from 762,000 at the end of the previous reported quarter. Sarbit Advisory Services Inc who had been investing in T Mobile Us Inc for a number of months, seems to be less bullish one the $48.50 billion market cap company. The stock rose 0.73% or $0.42 reaching $58.72. About 2.00M shares traded. T-Mobile US Inc (NYSE:TMUS) has risen 62.63% since November 3, 2016 and is uptrending. It has outperformed by 45.93% the S&P500.Schafer Cullen Capital Management Inc decreased its stake in Glaxosmithkline Plc (Adr) (GSK) by 13.38% based on its latest 2017Q2 regulatory filing with the SEC. Schafer Cullen Capital Management Inc sold 308,551 shares as the company’s stock rose 5.47% with the market. The hedge fund held 2.00 million shares of the major pharmaceuticals company at the end of 2017Q2, valued at $86.10M, down from 2.31M at the end of the previous reported quarter. Schafer Cullen Capital Management Inc who had been investing in Glaxosmithkline Plc (Adr) for a number of months, seems to be less bullish one the $88.84B market cap company. The stock rose 0.42% or $0.15 reaching $36.09. About 2.56 million shares traded. GlaxoSmithKline plc (ADR) (NYSE:GSK) has risen 4.26% since November 3, 2016 and is uptrending. It has underperformed by 12.44% the S&P500.Sarbit Advisory Services Inc, which manages about $324.28 million US Long portfolio, upped its stake in On Track Innovation Ltd (NASDAQ:OTIV) by 394,051 shares to 1.31M shares, valued at $1.72M in 2017Q2, according to the filing. More notable recent T-Mobile US Inc (NASDAQ:TMUS) news were published by: Reuters.com which released: “Japan’s SoftBank doubts merger of Sprint with T-Mobile: source” on October 30, 2017, also Nytimes.com with their article: “SoftBank, Deutsche Telekom Hit Wall in Sprint, T-Mobile Talks: Sources” published on October 31, 2017, Bizjournals.com published: “T-Mobile tweaks its merger offer as Sprint again eyes Charter deal” on November 03, 2017. More interesting news about T-Mobile US Inc (NASDAQ:TMUS) were released by: Reuters.com and their article: “T-Mobile, Sprint deal likely opposed by Justice Dept staff: sources” published on October 11, 2017 as well as Reuters.com‘s news article titled: “Exclusive: T-Mobile, Sprint plan merger without selling assets” with publication date: October 15, 2017.Investors sentiment increased to 1.36 in 2017 Q2. Its up 0.14, from 1.22 in 2017Q1. It is positive, as 58 investors sold TMUS shares while 140 reduced holdings. 82 funds opened positions while 187 raised stakes. 278.36 million shares or 0.37% less from 279.41 million shares in 2017Q1 were reported. Dnb Asset Mgmt As owns 299,815 shares or 0% of their US portfolio. Alpine Woods Cap Invsts Limited Company holds 0.12% or 38,500 shares. Meru Capital Group Lp holds 19.98% or 100,000 shares in its portfolio. Northwestern Mutual Wealth Management reported 1,869 shares stake. Alexandria Capital Ltd Liability Company stated it has 78 shares or 0% of all its holdings. Arrowgrass Cap Prns (Us) Lp holds 0.79% or 1.71M shares in its portfolio. Qs Ltd Liability Com holds 0.01% of its portfolio in T-Mobile US Inc (NASDAQ:TMUS) for 20,886 shares. Ipg Lc reported 5,385 shares. Clinton Gru has invested 0.35% in T-Mobile US Inc (NASDAQ:TMUS). Oppenheimer Co holds 0.05% of its portfolio in T-Mobile US Inc (NASDAQ:TMUS) for 28,740 shares. Sheets Smith Wealth invested in 36,516 shares. Lone Pine Ltd Liability Com has invested 2.2% in T-Mobile US Inc (NASDAQ:TMUS). Insight Cap & Mngmt Incorporated reported 16,189 shares. Martingale Asset Management LP stated it has 30,147 shares or 0.03% of all its holdings. Winfield Assocs Inc has 0.01% invested in T-Mobile US Inc (NASDAQ:TMUS).Among 30 analysts covering T-Mobile US (NYSE:TMUS), 21 have Buy rating, 1 Sell and 8 Hold. Therefore 70% are positive. T-Mobile US had 61 analyst reports since August 3, 2015 according to SRatingsIntel. On Monday, October 2 the stock rating was maintained by RBC Capital Markets with “Buy”. Jefferies maintained T-Mobile US Inc (NASDAQ:TMUS) rating on Tuesday, August 1. Jefferies has “Buy” rating and $8000 target. The stock of T-Mobile US Inc (NASDAQ:TMUS) earned “Neutral” rating by Moffett Nathanson on Tuesday, January 10. Credit Suisse maintained the shares of TMUS in report on Friday, June 23 with “Hold” rating. Deutsche Bank downgraded T-Mobile US Inc (NASDAQ:TMUS) on Thursday, April 6 to “Hold” rating. Goldman Sachs maintained the shares of TMUS in report on Tuesday, October 31 with “Buy” rating. The firm earned “Buy” rating on Tuesday, September 5 by Jefferies. The stock of T-Mobile US Inc (NASDAQ:TMUS) earned “Mkt Perform” rating by FBR Capital on Tuesday, October 25. KeyBanc Capital Markets maintained T-Mobile US Inc (NASDAQ:TMUS) on Wednesday, October 11 with “Buy” rating. The rating was maintained by FBR Capital with “Outperform” on Wednesday, January 11.Among 15 analysts covering GlaxoSmithKline (NYSE:GSK), 6 have Buy rating, 1 Sell and 8 Hold. Therefore 40% are positive. GlaxoSmithKline had 23 analyst reports since September 8, 2015 according to SRatingsIntel. BNP Paribas upgraded the shares of GSK in report on Tuesday, September 15 to “Neutral” rating. The rating was downgraded by Citigroup to “Neutral” on Wednesday, July 5. Argus Research maintained GlaxoSmithKline plc (ADR) (NYSE:GSK) rating on Monday, December 7. Argus Research has “Buy” rating and $48 target. The firm earned “Underperform” rating on Wednesday, September 14 by BNP Paribas. The firm earned “Buy” rating on Wednesday, January 27 by Bryan Garnier & Cie. The rating was downgraded by Bank of America on Thursday, October 26 to “Hold”. The stock of GlaxoSmithKline plc (ADR) (NYSE:GSK) earned “Buy” rating by Investec on Thursday, October 20. The stock of GlaxoSmithKline plc (ADR) (NYSE:GSK) has “Neutral” rating given on Wednesday, April 26 by JP Morgan. The stock of GlaxoSmithKline plc (ADR) (NYSE:GSK) earned “Neutral” rating by Bank of America on Tuesday, September 8. The stock of GlaxoSmithKline plc (ADR) (NYSE:GSK) has “Buy” rating given on Friday, August 12 by Argus Research.Schafer Cullen Capital Management Inc, which manages about $10.62B and $8.04 billion US Long portfolio, upped its stake in Vina Concha Y Toro Sa (Adr) (NYSE:VCO) by 10,240 shares to 141,259 shares, valued at $4.38 million in 2017Q2, according to the filing. It also increased its holding in Roche Holding Ag (RHHVF) by 1,714 shares in the quarter, for a total of 7,436 shares, and has risen its stake in Bce Inc. (NYSE:BCE). Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.



(adsbygoogle = window.adsbygoogle || []).push({});
